This 2024 case study describes how a clinical-stage biopharmaceutical company focused on innovative cell therapies modernized subpar legacy infrastructure made up of outdated components, limited redundancy, and minimal monitoring. Brillio led modernization and cloud migration using its BrillioOne.ai framework to choose migration strategies, upgrade an R&D application, and improve usability, accessibility, and performance. The engagement also established a content management capability for generating and managing website content, plus a controlled environment intended to optimize user experience. To meet pharma regulatory expectations, Brillio implemented an adaptable compliance control system and strengthened operations support, including directory services administration, GPO management,

Join for free to read